Add to favourites
News Local and Global in your language
18th of November 2018

Health



New Treatment Approved for Opioid Dependence

MONDAY, Sept. 10, 2018 (HealthDay News) -- Cassipa (buprenorphine and naloxone), a film designed to be placed under the tongue, has been approved to treat opioid dependence, the agency said in a news release.

Latest Chronic Pain News

Both buprenorphine and naloxone have been approved previously for this purpose.

"Opioid replacement therapy can be an important part of effective treatment," said FDA Commissioner Dr. Scott Gottlieb. "Opioid use disorder should be viewed similarly to any other chronic condition that is treated with medication."

The newly approved drug duo should be part of a complete treatment plan that includes counseling and psychosocial support to treat people with opioid use disorder. Cassipa may only be dispensed by approved prescribers, the agency said.

Side effects of the drugs include oral numbness, burning mouth, inflammation of the mouth's mucous membrane, headache, nausea, vomiting, excessive sweating and constipation.

Cassipa is produced by Teva Pharmaceuticals USA, based in New Jersey. Its parent company is located in Israel.

-- Scott Roberts

MedicalNewsCopyright © 2018 HealthDay. All rights reserved.

Read More




Leave A Comment

More News

NYT > Health

Scientific American: Health

MedicineNet Daily News

FOXNews.com

Disclaimer and Notice:WorldProNews.com is not the owner of these news or any information published on this site.